We updated the design of this site on September 25th. Learn more.
Show more
ClinicalTrials.gov
ClinicalTrials.gov Menu

A Pilot Study on the Effects of ILARIS® on Patients With Proliferative Diabetic Retinopathy (PDRP) (ILARIS)

This study has been terminated.
(The results of the interim analysis showed that the primary endpoint was not met)
Sponsor:
ClinicalTrials.gov Identifier:
NCT01589029
First Posted: May 1, 2012
Last Update Posted: November 24, 2015
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
Collaborators:
Novartis
University Hospital, Zürich
Information provided by (Responsible Party):
PD Dr. med. Stephan Michels, Triemli Hospital
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study has been terminated.
  Study Completion Date: November 2014
  Primary Completion Date: November 2014 (Final data collection date for primary outcome measure)